Nifty
Sensex
:
:
12987.00
44259.74
128.60 (1.00%)
431.64 (0.98%)

Pharmaceuticals & Drugs

Rating :
81/99  (View)

BSE: 540737 | NSE: Not Listed

145.50
9.55 (7.02%)
26-Nov-2020 | 4:01PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  145.00
  •  162.30
  •  130.10
  •  135.95
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  13201
  •  19.21
  •  162.30
  •  53.43

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 136.04
  • 12.99
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 138.18
  • 0.99%
  • 3.15

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 63.57%
  • 0.75%
  • 35.11%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 0.57%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

Quarterly Results

Standalone Figures in Rs. Crores

Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
0
0
0
0
0
0
0
0
0
0
0
0
Expenses
0
0
0
0
0
0
0
0
0
0
0
0
EBITDA
0
0
0
0
0
0
0
0
0
0
0
0
EBIDTM
0%
0%
0%
0%
0%
0%
0%
0%
Other Income
0
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
PBT
0
0
0
0
0
0
0
0
0
0
0
0
Tax
0
0
0
0
0
0
0
0
0
0
0
0
PAT
0
0
0
0
0
0
0
0
0
0
0
0
PATM
0%
0%
0%
0%
0%
0%
0%
0%
EPS
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 20
Mar 19
Net Sales
-
64
35
Net Sales Growth
-
81%
 
Cost Of Goods Sold
-
38
18
Gross Profit
-
26
17
GP Margin
-
41%
48%
Total Expenditure
-
52
27
Power & Fuel Cost
-
2
1
% Of Sales
-
2%
2%
Employee Cost
-
3
2
% Of Sales
-
5%
5%
Manufacturing Exp.
-
1
1
% Of Sales
-
1%
2%
General & Admin Exp.
-
7
4
% Of Sales
-
11%
10%
Selling & Distn. Exp.
-
1
1
% Of Sales
-
2%
3%
Miscellaneous Exp.
-
0
0
% Of Sales
-
0%
0%
EBITDA
-
13
9
EBITDA Margin
-
20%
25%
Other Income
-
4
1
Interest
-
1
0
Depreciation
-
2
1
PBT
-
14
9
Tax
-
3
2
Tax Rate
-
23%
28%
PAT
-
10
6
PAT before Minority Interest
-
10
6
Minority Interest
-
0
0
PAT Margin
-
16%
18%
PAT Growth
-
68%
 
EPS
-
10.47
6.24

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 20
Mar 19
Shareholder's Funds
42
34
Share Capital
9
9
Total Reserves
33
25
Non-Current Liabilities
3
1
Secured Loans
0
0
Unsecured Loans
2
0
Long Term Provisions
0
0
Current Liabilities
10
7
Trade Payables
5
4
Other Current Liabilities
0
0
Short Term Borrowings
2
0
Short Term Provisions
4
2
Total Liabilities
55
41
Net Block
20
14
Gross Block
29
21
Accumulated Depreciation
9
7
Non Current Assets
21
16
Capital Work in Progress
0
0
Non Current Investment
0
0
Long Term Loans & Adv.
1
1
Other Non Current Assets
0
0
Current Assets
34
26
Current Investments
3
4
Inventories
6
7
Sundry Debtors
18
10
Cash & Bank
2
1
Other Current Assets
4
0
Short Term Loans & Adv.
4
5
Net Current Assets
23
19
Total Assets
55
41

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 20
Mar 19
Cash From Operating Activity
5
-5
PBT
14
9
Adjustment
-4
0
Changes in Working Capital
-5
-14
Cash after chg. in Working capital
5
-5
Interest Paid
0
0
Tax Paid
0
0
Other Direct Exp. Paid
0
0
Extra & Other Items
0
0
Cash From Investing Activity
-3
0
Net Fixed Assets
-4
Net Investments
-3
Others
4
Cash from Financing Activity
0
0
Net Cash Inflow / Outflow
1
-5
Opening Cash & Equivalents
1
6
Closing Cash & Equivalent
2
1

Financial Ratios

Standalone /

Consolidated
Description
Mar 20
Mar 19
Book Value (Rs.)
42
34
ROA
22%
15%
ROE
28%
18%
ROCE
35%
26%
Fixed Asset Turnover
2.57
1.68
Receivable days
78
100
Inventory Days
37
67
Payable days
32
55
Cash Conversion Cycle
83
113
Total Debt/Equity
0.11
0.02
Interest Cover
26
43

News Update


  • Shree Ganesh Remedies gets nod for migrating Shares from SME platform to BSE
    24th Nov 2020, 16:16 PM

    The company has received approval from BSE for migrating the 10,006,446 Equity Shares of the Company

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.